कंपनी का अवलोकन
Braskem S.A. operates within the basic materials sector, specifically focusing on the chemical industry in Brazil, where it manufactures, sells, imports, and exports a comprehensive range of products including polyethylene, polypropylene, tertiary-butyl ethyl ether, gasoline, benzene, toluene, xylene, ethylene, and propylene. This positioning as a primary producer of petrochemicals and fuels establishes the firm as a fundamental component of the nation's industrial supply chain, catering to downstream manufacturing needs. The company's current market capitalization stands at $1.44B, while its trailing twelve-month revenue is reported at $70.72B, reflecting a substantial operational footprint despite the absence of publicly disclosed employee count data. These financial metrics indicate that Braskem holds a significant revenue-generating position within the Brazilian chemical landscape, although the relatively modest market cap relative to its revenue suggests a specific market valuation context or potential challenges in converting earnings into equity value. The scale of operations, evidenced by the $70.72B in annual revenue, places the entity among the larger players in its domestic sector, yet the market cap figure of $1.44B implies that the market is currently pricing the stock with caution regarding its future earnings potential or asset quality.
वित्तीय स्वास्थ्य
The company reported a trailing twelve-month revenue of $70.72B, yet this gross revenue resulted in a net income of $-9,880,000,512, revealing a deeply distressed cost structure where operating expenses and losses significantly outweighed total sales. Despite this net loss, the EBITDA remained positive at $4.02B, indicating that the core business operations before interest, taxes, depreciation, and amortization still generate cash, although the substantial net loss suggests heavy interest burdens or one-time charges impacting the bottom line. Free cash flow stands at $-5,425,999,872, which signals a severe lack of financial flexibility, as the company is consuming cash faster than it can generate it from its operations and investing activities. The margin analysis highlights a gross margin of 4.8%, an operating margin of 15.0%, and a negative profit margin of -14.0%, illustrating a scenario where high operating efficiency is being eroded by significant financial costs or asset impairments that depress the final profitability. On the balance sheet, total cash reserves of $11.84B are far below total debt obligations of $71.32B, creating a highly leveraged position where the company relies heavily on external financing to sustain operations. Although the debt-to-equity ratio is not disclosed, the disparity between cash and debt clearly points to a risky leverage profile. Additionally, the current ratio is 0.76, indicating that current assets are insufficient to cover current liabilities without liquidating long-term assets, which points to potential short-term liquidity stress. Return on Equity is not available, but the Return on Assets is a minimal 0.2%, suggesting that management is currently unable to generate substantial returns on the capital base employed in the business.
मूल्यांकन आकलन
The valuation metrics present a complex picture, with a trailing P/E ratio listed as N/A due to the negative net income, while the forward P/E is -4.54, a negative figure that implies the market is not expecting near-term earnings recovery to traditional profitability levels. The price-to-book ratio is -0.93, indicating that the market values the company at less than its book value and that the equity has a negative valuation relative to assets, a situation often seen in distressed or heavily leveraged firms. Alternative valuation metrics such as the price-to-sales ratio of 0.02 and an EV/EBITDA of 15.44 suggest that investors are pricing the stock based on minimal sales multiples while acknowledging the high enterprise value relative to earnings before interest, taxes, depreciation, and amortization. The 52-week price range spans from a low of $2.32 to a high of $5.29, meaning the current trading price is situated within this historical band, reflecting recent volatility but also providing a benchmark for entry and exit points relative to the asset's recent performance history. The stock exhibits a beta of 0.75, which indicates that its price volatility is lower than the broader market, suggesting that the stock is less sensitive to general market movements and may offer a different risk profile compared to more cyclical or aggressive basic materials peers.
Growth & Income
Revenue growth year-over-year is -15.9%, while earnings growth is N/A due to the negative earnings base, indicating that the company is currently contracting in terms of top-line sales rather than expanding. Since earnings are negative, the comparison of earnings growth to revenue growth is not mathematically standard, but the contraction in revenue suggests a challenging operating environment that is likely contributing to the massive net losses observed. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, meaning that all available cash is theoretically retained or required for debt servicing rather than distributed to shareholders. This reinvestment strategy, or lack thereof given the cash burn, implies that the company is not currently prioritizing income generation for investors but is instead focused on survival, debt reduction, or potential restructuring efforts. The overall growth and income profile for Braskem S.A. is characterized by significant revenue contraction, negative profitability, and an absence of dividend distributions, presenting a challenging investment case typical of a company in deep distress within the chemicals sector.